| Dr Adrianne J Ross, DPM | |
|
1815 Highway 138 Se, Suite 600, Conyers, GA 30013-2079 | |
| (770) 922-8922 | |
| (770) 922-8956 |
| Full Name | Dr Adrianne J Ross |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 16 Years |
| Location | 1815 Highway 138 Se, Conyers, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639478407 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | SC006076 (Pennsylvania) | Secondary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | POD001201 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emory Hillandale Hospital | Lithonia, GA | Hospital |
| Provider Name | Foot And Ankle Institute Of Georgia |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649631037 PECOS PAC ID: 7719276310 Enrollment ID: O20160521000101 |
News Archive
Sangamo BioSciences, Inc. today announced the pricing of its previously announced public offering of 6,700,000 shares of its common stock at a price to the public of $7.70 per share. The public offering is expected to close on or around Wednesday, April 13, 2011, subject to customary closing conditions.
ExonHit Therapeutics today announced the signing of an exclusive agreement with Genmab A/S for a selection of novel splice variants, identified as part of a successful pilot study, that have the potential to be therapeutic targets for breast cancer. Genmab retains exclusive development and commercialization rights on 10 events out of a breast cancer database developed using ExonHit's genome-wide SpliceArray technology (RNA splicing analysis platform covering the entire genome).
An international team of researchers led by the University of East Anglia (UEA) have developed a new kind of endoscope to aid the early detection and diagnosis of inflammatory bowel disease.
The next generation of case management guidelines for childhood illness need to be more locally informed, rather than relying on those centrally generated by organizations like the World Health Organization (WHO), argues a new essay published in the open access journal PLoS Medicine.
Even moderate drinking (four drinks or more per week) can increase the risk of cancer and an early death, according to a new study.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adrianne J Ross, DPM 470 E Pharr Rd, Decatur, GA 30030-4426 Ph: (770) 922-8922 | Dr Adrianne J Ross, DPM 1815 Highway 138 Se, Suite 600, Conyers, GA 30013-2079 Ph: (770) 922-8922 |
News Archive
Sangamo BioSciences, Inc. today announced the pricing of its previously announced public offering of 6,700,000 shares of its common stock at a price to the public of $7.70 per share. The public offering is expected to close on or around Wednesday, April 13, 2011, subject to customary closing conditions.
ExonHit Therapeutics today announced the signing of an exclusive agreement with Genmab A/S for a selection of novel splice variants, identified as part of a successful pilot study, that have the potential to be therapeutic targets for breast cancer. Genmab retains exclusive development and commercialization rights on 10 events out of a breast cancer database developed using ExonHit's genome-wide SpliceArray technology (RNA splicing analysis platform covering the entire genome).
An international team of researchers led by the University of East Anglia (UEA) have developed a new kind of endoscope to aid the early detection and diagnosis of inflammatory bowel disease.
The next generation of case management guidelines for childhood illness need to be more locally informed, rather than relying on those centrally generated by organizations like the World Health Organization (WHO), argues a new essay published in the open access journal PLoS Medicine.
Even moderate drinking (four drinks or more per week) can increase the risk of cancer and an early death, according to a new study.
› Verified 7 days ago
Foot And Ankle Reconstruction Center Of Georgia Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 1025 E Freeway Dr Se, Conyers, GA 30094 Phone: 937-477-4445 | |
Ankle And Foot Specialists Of Rockdale Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1025 E Freeway Dr Se, Conyers, GA 30094 Phone: 770-929-3338 | |
Shadae Mcmillan, FNP-C Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1412 Milstead Ave Ne, Conyers, GA 30012 Phone: 770-918-3000 | |
James Edwin Williams Jr., D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 1025 E Freeway Dr Se, Conyers, GA 30094 Phone: 770-929-3338 Fax: 770-760-7942 | |
Associated Foot And Ankle Specialists Podiatrist Medicare: Medicare Enrolled Practice Location: 1567 Milstead Rd Ne Ste A, Conyers, GA 30012 Phone: 770-483-2291 Fax: 770-483-2927 | |
Dr. Ketan B Patel, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1720 Honey Creek Commons, Ste B, Conyers, GA 30013 Phone: 770-483-1100 Fax: 770-483-5855 |